Ptc Therapeutics (PTCT) Assets Average (2013 - 2026)

Ptc Therapeutics' Assets Average history runs 14 years deep, the most recent figure standing at $2.9 billion for Q1 2026.

• In Q1 2026, Assets Average rose 32.28% year-over-year to $2.9 billion; the TTM figure through Mar 2026 stood at $2.9 billion (up 32.28% YoY), while the FY2025 annual figure was $2.3 billion, up 27.86% from the prior year.
• Assets Average was $2.9 billion for Q1 2026 at Ptc Therapeutics, up from $2.8 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $2.9 billion in Q1 2026 to a low of $1.3 billion in Q3 2023.
• Historically, Assets Average has averaged $2.0 billion across 5 years, with a median of $1.8 billion in 2024.
• The sharpest annual moves came in 2023 and 2025: Assets Average retreated 23.15% in 2023, then jumped 56.25% in 2025.
• A 5-year view of Assets Average shows it stood at $1.6 billion in 2022, then retreated by 3.85% to $1.6 billion in 2023, then rose by 12.41% to $1.8 billion in 2024, then surged by 56.25% to $2.8 billion in 2025, then gained by 4.07% to $2.9 billion in 2026.
• The last three Assets Average figures came in at $2.9 billion (Q1 2026), $2.8 billion (Q4 2025), and $2.6 billion (Q3 2025), per Business Quant data.